# Effect of Selective and Nonselective Cyclooxygenase Enzyme Inhibition on Arterial Blood Pressure and Cerebral Blood Flow With Exposure to Intermittent Hypoxia in Humans

> **NCT01280006** · PHASE1,PHASE2 · COMPLETED · sponsor: **University of Calgary** · enrollment: 12 (actual)

## Conditions studied

- Obstructive Sleep Apnea
- Hypertension
- Cardiovascular Diseases
- Stroke

## Interventions

- **OTHER:** Intermittent hypoxia
- **DRUG:** Indomethacin
- **DRUG:** Celecoxib
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01280006
- **Lead sponsor:** University of Calgary
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2011-12-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01280006

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01280006, "Effect of Selective and Nonselective Cyclooxygenase Enzyme Inhibition on Arterial Blood Pressure and Cerebral Blood Flow With Exposure to Intermittent Hypoxia in Humans". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01280006. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*